Search Results - E. E. Gubar'

Refine Results
  1. 1
    Axial involvement in psoriatic arthritis

    Axial involvement in psoriatic arthritis by E. E. Gubar, T. V. Korotaeva

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    THE EARLY DIAGNOSIS AND CLINICAL FEATURES OF AXIAL SPONDYLOARTHRITIS AT THE EUROPEAN CONGRESS OF RHEUMATOLOGY 2015

    THE EARLY DIAGNOSIS AND CLINICAL FEATURES OF AXIAL SPONDYLOARTHRITIS AT THE EUROPEAN CONGRESS OF RHEUMATOLOGY 2015 by E. E. Gubar, Sh. F. Erdes

    Published 2016-09-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS

    EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS by E E Gubar', A G Bochkova, N V Bunchuk, E E Gubar, A G Bochkova, N V Bunchuk

    Published 2011-04-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS

    SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS by E. E. Gubar, E. Yu. Loginova, T. V. Korotaeva

    Published 2018-11-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Involvement of the axial skeleton in psoriatic arthritis

    Involvement of the axial skeleton in psoriatic arthritis by E. E. Gubar, E. Yu. Loginova, T. V. Korotaeva

    Published 2017-03-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    SRAVNENIE TROYNOY KOMBINIROVANNOY TERAPII METOTREKSATOM, SUL'FASALAZINOM I GIDROKSIKhLOROKhINOM S MONOTERAPIEY METOTREKSATOM PRI REVMATOIDNOM ARTRITE (PREDVARITEL'NYE DANNYE)

    SRAVNENIE TROYNOY KOMBINIROVANNOY TERAPII METOTREKSATOM, SUL'FASALAZINOM I GIDROKSIKhLOROKhINOM S MONOTERAPIEY METOTREKSATOM PRI REVMATOIDNOM ARTRITE (PREDVARITEL'NYE DANNYE) by E E Gubar', А Г Бочкова, N V Bunchuk

    Published 2005-06-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Prognostic factors associated with achieving minimal disease activity in early psoriatic arthritis patients treated according to “treat-to-target” st rategy within 12 months

    Prognostic factors associated with achieving minimal disease activity in early psoriatic arthritis patients treated according to “treat-to-target” st rategy within 12 months by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, S. I. Glukhova

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    The safety and optimal dosage of an interleukin-17A inhibitor (secukinumab) in the treatment of psoriatic arthritis in a patient with concomitant hepatitis C virus infection

    The safety and optimal dosage of an interleukin-17A inhibitor (secukinumab) in the treatment of psoriatic arthritis in a patient with concomitant hepatitis C virus infection by E. E. Gubar, T. V. Korotaeva, A. S. Starkova, M. M. Urumova

    Published 2019-10-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Experience in using secukinumab in patients with axial psoriatic arthritis

    Experience in using secukinumab in patients with axial psoriatic arthritis by E. E. Gubar, Yu. L. Korsakova, E. Yu. Loginova, T. V. Korotaeva

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Comparative characteristics of early psoriatic arthritis with and without axial skeleton injury (a subanalysis of the all-Russian registry of patients with psoriatic arthritis)

    Comparative characteristics of early psoriatic arthritis with and without axial skeleton injury (a subanalysis of the all-Russian registry of patients with psoriatic arthritis) by E. E. Gubar, E. Yu. Loginova, T. V. Korotaeva, S. I. Glukhova, E. L. Nasonov

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Possibilities of screening for a high-risk axial skeletal lesion in psoriatic arthritis

    Possibilities of screening for a high-risk axial skeletal lesion in psoriatic arthritis by E. E. Gubar, E. Yu. Loginova, Yu. L. Korsakova, S. I. Glukhova, T. V. Korotaeva

    Published 2020-09-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE

    EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE by E. Yu. Loginova, Yu. L. Korsakova, E. E. Gubar, P. L. Karpova, T. V. Korotaeva

    Published 2020-06-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Psoriatic arthritis. Clinical guidelines for diagnosis and treatment

    Psoriatic arthritis. Clinical guidelines for diagnosis and treatment by T. V. Korotaeva, Yu. L. Korsakova, E. Yu. Loginova, E. E. Gubar, M. N. Chamurlieva

    Published 2018-06-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis

    Difficult-to-treat psoriatic arthritis. Data from the All-Russian registry of patients with psoriatic arthritis by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, E. L. Nasonov

    Published 2024-10-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Prognostic factors associated with non-remission and low disease activity status af ter one year of psoriatic arthritis patients treatment in real practice

    Prognostic factors associated with non-remission and low disease activity status af ter one year of psoriatic arthritis patients treatment in real practice by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, S. I. Glukhova, E. L. Nasonov

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    7 year of sacroiliac radiographic progression in early psoriatic arthritis (preliminary results)

    7 year of sacroiliac radiographic progression in early psoriatic arthritis (preliminary results) by E. Yu. Loginova, P. O. Tremaskina, E. E. Gubar, T. V. Korotaeva, A. V. Sukhinina, S. I. Glukhova

    Published 2024-03-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    2-years outcomes of the treat-to-target strategy in early psoriatic arthritis

    2-years outcomes of the treat-to-target strategy in early psoriatic arthritis by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, P. O. Tremaskina, S. I. Glukhova, E. L. Nasonov

    Published 2022-11-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF AXIAL LESION IN EARLY PERIPHERAL PSORIATIC ARTHRITIS (DATA OF A REMARCA STUDY)

    CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF AXIAL LESION IN EARLY PERIPHERAL PSORIATIC ARTHRITIS (DATA OF A REMARCA STUDY) by E. E. Gubar, E. Yu. Loginova, A. V. Smirnov, S. I. Glukhova, T. V. Korotaeva, E. L. Nasonov

    Published 2018-03-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Effect of tofacitinib treatment on active MRI sacroiliitis in psoriatic arthritis patients

    Effect of tofacitinib treatment on active MRI sacroiliitis in psoriatic arthritis patients by E. E. Gubar, Yu. L. Korsakova, E. Yu. Loginova, A. V. Smirnov, S. I. Glukhova, T. V. Korotaeva

    Published 2021-05-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Search for predictors of achieving minimal disease activity during tofacitinib therapy in patients with psoriatic arthritis

    Search for predictors of achieving minimal disease activity during tofacitinib therapy in patients with psoriatic arthritis by L. D. Vorobyova, T. V. Korotaeva, S. I. Glukhova, E. Yu. Loginova, E. E. Gubar, Yu. L. Korsakova

    Published 2023-12-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: